|
1
|
Keeley EC, Boura JA and Grines CL: Primary
angioplasty versus intravenous thrombolytic therapy for acute
myocardial infarction: A quantitative review of 23 randomised
trials. Lancet. 361:13–20. 2003.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Turak O, Ozcan F, Isleyen A, Tok D, Sokmen
E, Buyukkaya E, Aydogdu S, Akpek M and Kaya MG: Usefulness of the
neutrophil-to-lymphocyte ratio to predict bare-metal stent
restenosis. Am J Cardiol. 110:1405–1410. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
De Luca G, Dirksen MT, Spaulding C,
Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser
C, Musto C, et al: Drug-Eluting Stent in Primary Angioplasty
(DESERT) Cooperation: Drug-eluting vs bare-metal stents in primary
angioplasty: A pooled patient-level meta-analysis of randomized
trials. Arch Intern Med. 172:611–622. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jukema JW, Verschuren JJW, Ahmed TAN and
Quax PHA: Restenosis after PCI. Part 1: Pathophysiology and risk
factors. Nat Rev Cardiol. 9:53–62. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li J-J, Ren Y, Chen K-J, Yeung AC, Xu B,
Ruan XM, Yang YJ, Chen JL and Gao RL: Impact of C-reactive protein
on in-stent restenosis: A meta-analysis. Tex Heart Inst J.
37:49–57. 2010.PubMed/NCBI
|
|
6
|
Bolca O, Güngör B, Özcan KS, Karadeniz FÖ,
Sungur A, Köroğlu B, Bakhshyaliyev N, Yelgeç NS, Karataş B, İpek G,
et al: The neutrophil-to-lymphocyte ratio is associated with
bare-metal stent restenosis in STEMI patients treated with primary
PCI. Coron Artery Dis. 26:402–408. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
AlFaleh HF, Alsuwaida AO, Ullah A, Hersi
A, AlHabib KF, AlNemer K, AlSaif S, Taraben A, Kashour T, Balghith
MA, et al: The prognostic impact of in-hospital worsening of renal
function in patients with acute coronary syndrome. Int J Cardiol.
167:866–870. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Amin AP, Spertus JA, Reid KJ, Lan X,
Buchanan DM, Decker C and Masoudi FA: The prognostic importance of
worsening renal function during an acute myocardial infarction on
long-term mortality. Am Heart J. 160:1065–1071. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Goldberg A, Hammerman H, Petcherski S,
Zdorovyak A, Yalonetsky S, Kapeliovich M, Agmon Y, Markiewicz W and
Aronson D: Inhospital and 1-year mortality of patients who develop
worsening renal function following acute ST-elevation myocardial
infarction. Am Heart J. 150:330–337. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Stefanini GG, Taniwaki M, Kalesan B, Räber
L, Stortecky S, Pilgrim T, Onuma Y, Silber S, Serruys PW, Meier B,
et al: The impact of renal impairment on long-term safety and
effectiveness of drug-eluting stents. PLoS One.
9(e106450)2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cassese S, Byrne RA, Tada T, Pinieck S,
Joner M, Ibrahim T, King LA, Fusaro M, Laugwitz KL and Kastrati A:
Incidence and predictors of restenosis after coronary stenting in
10 004 patients with surveillance angiography. Heart. 100:153–159.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Best PJM, Berger PB, Davis BR, Grines CL,
Sadeghi HM, Williams BA, Willerson JT, Granett JR and Holmes DR Jr:
PRESTO Investigators. Impact of mild or moderate chronic kidney
disease on the frequency of restenosis: Results from the PRESTO
trial. J Am Coll Cardiol. 44:1786–1791. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Marenzi G, Lauri G, Assanelli E,
Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F and
Bartorelli AL: Contrast-induced nephropathy in patients undergoing
primary angioplasty for acute myocardial infarction. J Am Coll
Cardiol. 44:1780–1785. 2004.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hao Y, Liu J, Liu J, Smith SC Jr, Huo Y,
Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, et al: CCC-ACS
Investigators: Rationale and design of the Improving Care for
Cardiovascular Disease in China (CCC) project: A national effort to
prompt quality enhancement for acute coronary syndrome. Am Heart J.
179:107–115. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shen W and Gao R: Chinese Society of
Cardiology. Guideline for diagnosis and treatment of patients with
ST-elevation myocardial infarction. China J Cardiol. 38:675–690.
2010.PubMed/NCBI
|
|
16
|
Killip T III and Kimball JT: Treatment of
myocardial infarction in a coronary care unit. A two year
experience with 250 patients. Am J Cardiol. 20:457–464.
1967.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Khot UN, Jia G, Moliterno DJ, Lincoff AM,
Khot MB, Harrington RA and Topol EJ: Prognostic importance of
physical examination for heart failure in non-ST-elevation acute
coronary syndromes: The enduring value of Killip classification.
JAMA. 290:2174–2181. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yamaguchi J, Kasanuki H, Ishii Y, Yagi M,
Nagashima M, Fujii S, Koyanagi R, Ogawa H, Hagiwara N, Haze K, et
al: HIJC Investigators: Serum creatinine on admission predicts
long-term mortality in acute myocardial infarction patients
undergoing successful primary angioplasty: Data from the Heart
Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry.
Circ J. 71:1354–1359. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Halkin A, Mehran R, Casey CW, Gordon P,
Matthews R, Wilson BH, Leon MB, Russell ME, Ellis SG and Stone GW:
Impact of moderate renal insufficiency on restenosis and adverse
clinical events after paclitaxel-eluting and bare metal stent
implantation: Results from the TAXUS-IV Trial. Am Heart J.
150:1163–1170. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang C-H, Zhang S-Y, Fang Q, Shen ZJ, Fan
ZJ, Jin XF, Zeng Y, Liu ZY and Xie HZ: Renal Dysfunction and hsCRP
Predict Long-term Outcomes of Percutaneous Coronary Intervention in
Acute Myocardial Infarction. Am J Med Sci. 349:413–420.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang RY, Zhu ZB, Zhang Q, Yang ZK, Hu J,
Lv AK, Zhang JS and Shen WF: Impact of moderate or severe renal
insufficiency on long-term outcomes in patients undergoing
drug-eluting stent based coronary intervention. Int J Cardiol.
136:72–79. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Garg P, Charytan DM, Novack L, Cutlip DE,
Popma JJ, Moses J, Leon MB, Schofer J, Breithardt G, Schampaert E,
et al: Impact of moderate renal insufficiency on restenosis and
adverse clinical events after sirolimus-eluting and bare metal
stent implantation (from the SIRIUS trials). Am J Cardiol.
106:1436–1442. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sahin I, Gungor B, Can MM, Avci II, Guler
GB, Okuyan E, Biter H, Yildiz SS, Ayca B, Satilmis S, et al: Lower
blood vitamin D levels are associated with an increased incidence
of contrast-induced nephropathy in patients undergoing coronary
angiography. Can J Cardiol. 30:428–433. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Seyfarth M, Kastrati A, Mann JFE, Ndrepepa
G, Byrne RA, Schulz S, Mehilli J and Schömig A: Prognostic value of
kidney function in patients with ST-elevation and non-ST-elevation
acute myocardial infarction treated with percutaneous coronary
intervention. Am J Kidney Dis. 54:830–839. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rubartelli P, Niccoli L, Verna E, Giachero
C, Zimarino M, Fontanelli A, Vassanelli C, Campolo L, Martuscelli E
and Tommasini G: Stent implantation versus balloon angioplasty in
chronic coronary occlusions: Results from the GISSOC trial. Gruppo
Italiano di Studio sullo Stent nelle Occlusioni Coronariche. J Am
Coll Cardiol. 32:90–96. 1998.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sahin I, Karabulut A, Avci II, Okuyan E,
Biter HI, Yildiz SS, Can MM, Gungor B, Dinckal M and Serebruany V:
Contribution of platelets indices in the development of
contrast-induced nephropathy. Blood Coagul Fibrinolysis.
26:246–249. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Börekçi A, Gür M, Türkoğlu C, Çaylı M,
Selek Ş, Kaypaklı O, Uçar H, Coşkun M, Şeker T, Koç M, et al:
Oxidative stress and paraoxonase 1 activity predict
contrast-induced nephropathy in patients with ST-segment elevation
myocardial infarction undergoing primary percutaneous coronary
intervention. Angiology. 66:339–345. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mizuguchi Y, Shibutani H, Hashimoto S,
Yamada T, Taniguchi N, Nakajima S, Hata T and Takahashi A:
Examination of the appropriate timing of reperfusion therapy for
recent myocardial infarction: A Japanese single-center
retrospective study. Indian Heart J. 70:4–9. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Caspi O, Habib M, Cohen Y, Kerner A,
Roguin A, Abergel E, Boulos M, Kapeliovich MR, Beyar R, Nikolsky E,
et al: Acute Kidney Injury After Primary Angioplasty: Is
Contrast-Induced Nephropathy the Culprit? J Am Heart Assoc.
6(6)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Velibey Y, Tanik O, Oz A, Guvenc TS,
Kalenderoglu K, Gumusdag A, Guzelburc O, Tekkesin AI, Uzun AO,
Alper AT, et al: Off-Hour Primary Percutaneous Coronary Angioplasty
Does Not Affect Contrast-Induced Nephropathy in Patients With
ST-Segment Elevation Myocardial Infarction. Angiology. 68:807–815.
2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Marrón B, Ruiz E, Fernández C, Almeida P,
Horcajada C, Navarro F and Caramelo C: Systemic and renal effects
of preventing contrast nephrotoxicity with isotonic (0.9%) and
hypotonic (0.45%) saline. Rev Esp Cardiol. 60:1018–1025.
2007.PubMed/NCBI View
Article : Google Scholar : (In Spanish).
|
